Ontology highlight
ABSTRACT: Background
Fetal growth restriction is a major determinant of perinatal morbidity and mortality. This condition has no gold standard definition, but a widely used proxy is delivery of a small for gestational age infant (<10th percentile) combined with an adverse pregnancy outcome. Effective screening for fetal growth restriction is an area of unmet clinical need. We aimed to determine the diagnostic effectiveness of a combination of ultrasonic fetal biometry and measurement of the ratio of soluble fms-like tyrosine kinase receptor 1 (sFLT1) to placental growth factor (PlGF) in predicting adverse pregnancy outcomes associated with delivery of a small for gestational age infant.Methods
In this prospective cohort study, using serial antenatal blood sampling and blinded ultraso
SUBMITTER: Gaccioli F
PROVIDER: S-EPMC6473551 | biostudies-literature | 2018 Aug
REPOSITORIES: biostudies-literature